Pharmacoeconomics and Pharmacovigilance: Citation and

Data Characteristics in This Domain

Pharmacoeconomics data in pharmacovigilance focuses on real-world evidence after drug market approval. This data comes from multi-center clinical studies, medical insurance payment databases, Electronic Health Record (EHR) systems, Patient-Reported Outcome (PRO) data, and various registry systems. Data update frequency is typically quarterly or annually. This depends on the data source's update cycle and the complexity of data cleaning. Document structures vary. Examples include research reports (PDF, Word), database export files (CSV, JSON), academic papers (PDF), and structured data tables (e.g., drug prices, treatment plan costs, adverse event rates).

Fields include general information like drug generic names, indications, and adverse event reports. They also include pharmacoeconomic-specific metrics: drug cost (drug_cost_unit), total therapy cost (total_therapy_cost), Quality-Adjusted Life Years (QALYs), and Incremental Cost-Effectiveness Ratio (ICER). Units typically involve currency (e.g., USD, CNY), time, and dimensionless ratios.

Constraints on Citation and Traceability

The diversity and multi-modal nature of pharmacoeconomics data present challenges for unified citation management. PDF research reports and academic papers require efficient text extraction and structured processing. This ensures accurate identification and indexing of key economic indicators. Structured data in database export files must retain field relationships during ingestion. An example is the correspondence between drug costs and specific treatment plans.

Lower data update frequency means the knowledge base should prioritize data sources reflecting the latest policies or clinical guideline changes during updates. Documents with many charts and tables require image recognition or table parsing support. This extracts pharmacoeconomic parameters from non-textual information. Citation traceability must precisely point to specific paragraphs or data tables in original documents. This is especially important for economic model parameters and calculation results to support conclusion reliability.

Configuration Guidelines

Configuration Item	Suggested Value	Rationale
`Chunk Size`	`500–800 characters`	Accommodates the long discursive paragraphs common in pharmacoeconomics reports, ensuring contextual completeness.
`Chunk Overlap`	`100–150 characters`	Ensures that economic indicators or chains of reasoning spanning multiple paragraphs are effectively linked, preventing information fragmentation.
`Recall Count`	`8–12 items`	Considers the complexity of pharmacoeconomic analysis, requiring more supporting evidence for conclusion generation.
`Similarity Threshold`	`0.75–0.82`	Balances accurate recall with noise avoidance, especially for economic literature containing many numbers and specialized terms.
`Rerank Return Count`	`5 items`	Refines the initial recall results to identify the most relevant evidence chains for pharmacoeconomic questions.
`PARSE_TABLE_ENABLED`	`true`	Ensures the ability to parse and utilize tables containing cost and benefit data from research reports.

Common Pitfalls

The answer does not mention local knowledge base content, but the citation list includes relevant documents. This may happen if the Similarity Threshold is set too high. The model then fails to effectively use recalled knowledge snippets that are low-similarity but relevant.
The citation source points to an empty or inaccessible original document. This usually occurs if the file path was stored incorrectly during knowledge base ingestion, or the original file was moved/deleted.
When asked about pharmacoeconomic indicators, the answer provides only general medical information. It lacks specific cost-benefit data or model parameters. This happens if the knowledge base fails to effectively identify and extract key economic data from tables or charts in unstructured documents, leading to missing indexes.

Verification Steps

Ask questions involving specific pharmacoeconomic indicators (e.g., ICER values, QALY gains). Verify that the answer accurately cites corresponding values from knowledge base documents and traces them to the exact location in the original document.
Upload a pharmacoeconomics research report containing complex tables. Ask questions about key data within the tables. Verify that the system correctly parses and cites the table content.
Simulate a scenario about drug cost-effectiveness. Ask the system how to evaluate the economic viability of a new drug. Check that the answer's cited evidence comprehensively covers costs, effects, and comparative analysis dimensions, and that sources are traceable.

The values given are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.